1887

Abstract

Prion diseases or transmissible spongiform encephalopathies (TSEs) are a group of rare, transmissible and fatal neurodegenerative diseases associated with the protein agent (PrP). As such, the sensitive and rapid detection of prion PrP amyloid on the surface of suspect surgical instruments is of great importance and may even allow remedial action to be taken prior to any further operative intervention and possible iatrogenic transmission. However, conventional PrP detection methodologies tend to rely on the inefficient and unreliable removal of suspect material from a surface using swabs or wipes prior to antibody analysis. Here we show how the combination of an advanced light microscope technique, episcopic differential interference contrast/epifluorescence (EDIC/EF) microscopy, and the application of -amyloid fluorescent thiazole markers (thioflavin T, thioflavin S) can be used to detect, , submicron (attomole) levels of prion protein amyloid contamination in brain and spleen sections, smears and homogenate on surgical stainless steel surfaces and surgical instruments. This technique, although not specific to an amyloid type, can be used to verify that surgical instruments are substantially free from prion amyloid protein soiling and hence reduce the risk of iatrogenic transmission.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82228-0
2007-09-01
2024-12-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/9/2619.html?itemId=/content/journal/jgv/10.1099/vir.0.82228-0&mimeType=html&fmt=ahah

References

  1. ACDP/SEAC 2003 Transmissible Spongiform Encephalopathy Agents: Safe Working and the Prevention of Infection London: The Stationery Office; http://www.advisorybodies.doh.gov.uk/acdp/tseguidance/Index.htm
    [Google Scholar]
  2. Appel T., Wolff M., von Rheinbaben F., Heinzel M., Riesner D. 2001; Heat stability of prion rods and recombinant prion protein in water, lipid and lipid-water mixtures. J Gen Virol 82:465–473
    [Google Scholar]
  3. Bancroft J. D., Stevens A. 1990 Theory and Practice of Histological Techniques , 3rd edition. Edinburgh: Churchill Livingstone;
    [Google Scholar]
  4. Bell J. E., Gentleman S. M., Ironside J. W., McCardle L., Lantos P. L., Doey L., Lowe J., Fergusson J., Luthert P. other authors 1997; Prion protein immunocytochemistry – UK five centre consensus report. Neuropathol Appl Neurobiol 23:26–35 [CrossRef]
    [Google Scholar]
  5. Bernoulli C., Siegfried J., Baumgartner G., Regli F., Rabinowicz T., Gajdusek D. C., Gibbs C. J., Jr. 1977; Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1:478–479
    [Google Scholar]
  6. Betmouni S., Perry V. H. 1999; The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate. Neuropathol Appl Neurobiol 25:20–28
    [Google Scholar]
  7. Bosque P. J., Ryou C., Telling G., Peretz D., Legname G., DeArmond S. J., Prusiner S. B. 2002; Prions in skeletal muscle. Proc Natl Acad Sci U S A 99:3812–3817 [CrossRef]
    [Google Scholar]
  8. Brown K. L., Ritchie D. L., McBride P. A., Bruce M. E. 2000; Detection of PrP in extraneural tissues. Microsc Res Tech 50:40–45 [CrossRef]
    [Google Scholar]
  9. Bruce M. E., Dickinson A. G., Fraser H. 1976; Cerebral amyloidosis in scrapie in the mouse: effect of agent strain and mouse genotype. Neuropathol Appl Neurobiol 2:471–478 [CrossRef]
    [Google Scholar]
  10. Burns J., Pennock C. A., Stoward P. J. 1967; The specificity of the staining of amyloid deposits with thioflavine T. J Pathol Bacteriol 94:337–344 [CrossRef]
    [Google Scholar]
  11. Collins S., Masters C. L. 1996; Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective. Med J Aust 164:598–602
    [Google Scholar]
  12. Cooley W. A., Clark J. K., Ryder S. J., Davis L. A., Farrelly S. S., Stack M. J. 2001; Evaluation of a rapid Western immunoblotting procedure for the diagnosis of bovine spongiform encephalopathy (BSE) in the UK. J Comp Pathol 125:64–70 [CrossRef]
    [Google Scholar]
  13. Davis J. M., Himwich W. A. 1973; Amino acids and proteins of developing mammalian brain. In Biochemistry of the Developing Brain p– 102 Edited by Himwich W. A. New York: Marcel Dekker;
    [Google Scholar]
  14. Dell'Omo G., Vannoni E., Vyssotski A. L., Di Bari M. A., Nonno R., Agrimi U., Lipp H. P. 2002; Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci 16:735–742 [CrossRef]
    [Google Scholar]
  15. Folch Pi J. 1955; In Biochemistry and the Developing Nervous System . pp 121–133 Edited by Waelsch H. New York: Academic Press;
  16. Franklin K., Paxinos G. 1997 The Mouse Brain in Stereotaxic Coordinates. San Diego London: Academic Press;
    [Google Scholar]
  17. Guntern R., Bouras C., Hof P. R., Vallet P. G. 1992; An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48:8–10 [CrossRef]
    [Google Scholar]
  18. Hachiya N. S., Imagawa M., Kaneko K. 2007; The possible role of protein X, a putative auxiliary factor in pathological prion replication, in regulating a physiological endoproteolytic cleavage of cellular prion protein. Med Hypotheses 68:670–673 [CrossRef]
    [Google Scholar]
  19. Hilton D. A., Ghani A. C., Conyers L., Edwards P., McCardle L., Ritchie D., Penney M., Hegazy D., Ironside J. W. 2004; Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203:733–739 [CrossRef]
    [Google Scholar]
  20. Hunter N., Foster J., Chong A., McCutcheon S., Parnham D., Eaton S., MacKenzie C., Houston F. 2002; Transmission of prion diseases by blood transfusion. J Gen Virol 83:2897–2905
    [Google Scholar]
  21. Ironside J. W. 2006; Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies. Haemophilia 12 (Suppl. 1):8–15
    [Google Scholar]
  22. Ishikawa K., Doh-ura K., Kudo Y., Nishida N., Murakami-Kubo I., Ando Y., Sawada T., Iwaki T. 2004; Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies. J Gen Virol 85:1785–1790 [CrossRef]
    [Google Scholar]
  23. Kascsak R. J., Rubenstein R., Merz P. A., Tonna-DeMasi M., Fersko R., Carp R. I., Wisniewski H. M., Diringer H. 1987; Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688–3693
    [Google Scholar]
  24. Keevil C. W. 2003; Rapid detection of biofilms and adherent pathogens using scanning confocal microscopy and episcopic differential interference contrast microscopy. Water Sci Technol 47:105–116
    [Google Scholar]
  25. Klunk W. E., Wang Y., Huang G. F., Debnath M. L., Holt D. P., Mathis C. A. 2001; Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69:1471–1484 [CrossRef]
    [Google Scholar]
  26. Kovacs G. G., Head M. W., Hegyi I., Bunn T. J., Flicker H., Hainfellner J. A., McCardle L., Laszlo L., Jarius C. other authors 2002; Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 12:1–11
    [Google Scholar]
  27. Lee D. C., Stenland C. J., Miller J. L., Cai K., Ford E. K., Gilligan K. J., Hartwell R. C., Terry J. C., Rubenstein R. other authors 2001; A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion 41:449–455 [CrossRef]
    [Google Scholar]
  28. Lipscomb I. P., Pinchin H. E., Collin R., Harris K., Keevil C. W. 2006a; The sensitivity of approved ninhydrin and Biuret tests in the assessment of protein contamination on surgical steel as an aid to prevent iatrogenic prion transmission. J Hosp Infect 64:288–292 [CrossRef]
    [Google Scholar]
  29. Lipscomb I. P., Sihota A. K., Botham M., Harris K. L., Keevil C. W. 2006b; Rapid method for the sensitive detection of protein contamination on surgical instruments. J Hosp Infect 62:141–148 [CrossRef]
    [Google Scholar]
  30. Lipscomb I. P., Sihota A. K., Keevil C. W. 2006c; Comparative study of surgical instruments from sterile-service departments for presence of residual gram-negative endotoxin and proteinaceous deposits. J Clin Microbiol 44:3728–3733 [CrossRef]
    [Google Scholar]
  31. Lipscomb I. P., Sihota A. K., Keevil C. W. 2006d; Diathermy forceps and pencils: reservoirs for protein and prion contamination?. J Hosp Infect 64:193–194 [CrossRef]
    [Google Scholar]
  32. Liu W. G., Brown D. A., Fraser J. R. 2003; Immunohistochemical comparison of anti-prion protein (PrP) antibodies in the CNS of mice infected with scrapie. J Histochem Cytochem 51:1065–1071 [CrossRef]
    [Google Scholar]
  33. Llewelyn C. A., Hewitt P. E., Knight R. S., Amar K., Cousens S., Mackenzie J., Will R. G. 2004; Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417–421 [CrossRef]
    [Google Scholar]
  34. Lockhart A., Ye L., Judd D. B., Merritt A. T., Lowe P. N., Morgenstern J. L., Hong G., Gee A. D., Brown J. 2005; Evidence for the presence of three distinct binding sites for the thioflavin T class of Alzheimer's disease PET imaging agents on β -amyloid peptide fibrils. J Biol Chem 280:7677–7684 [CrossRef]
    [Google Scholar]
  35. McBride P. A., Bruce M. E., Fraser H. 1988; Immunostaining of scrapie cerebral amyloid plaques with antisera raised to scrapie-associated fibrils (SAF). Neuropathol Appl Neurobiol 14:325–336 [CrossRef]
    [Google Scholar]
  36. Meyer-Luehmann M., Coomaraswamy J., Bolmont T., Kaeser S., Schaefer C., Kilger E., Neuenschwander A., Abramowski D., Frey P. other authors 2006; Exogenous induction of cerebral β -amyloidogenesis is governed by agent and host. Science 313:1781–1784 [CrossRef]
    [Google Scholar]
  37. Mouse Brain Library. 2002) http://www.mbl.org/
  38. NHS Estates 1997 Washer-Disinfectors: Validation and Verification . Health Technical Memorandum 2030 Edited by NHS Estates London: The Stationery Office; http://195.92.246.148/knowledge_network/documents/HTM2030%20Washer-disinfectors%20Operational%20management%202003123145743890.pdf
    [Google Scholar]
  39. Pan T., Chang B., Wong P., Li C., Li R., Kang S. C., Robinson J. D., Thompsett A. R., Tein P. other authors 2005; An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrPSc aggregates. J Virol 79:12355–12364 [CrossRef]
    [Google Scholar]
  40. Pauli G. 2005; Tissue safety in view of CJD and variant CJD. Cell Tissue Bank 6:191–200 [CrossRef]
    [Google Scholar]
  41. Peden A. H., Head M. W., Ritchie D. L., Bell J. E., Ironside J. W. 2004; Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527–529 [CrossRef]
    [Google Scholar]
  42. Peden A. H., Ritchie D. L., Head M. W., Ironside J. W. 2006; Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168:927–935 [CrossRef]
    [Google Scholar]
  43. Prusiner S. B. 1998; The prion diseases. Brain Pathol 8:499–513
    [Google Scholar]
  44. Riek R. 2006; Cell biology: infectious Alzheimer's disease?. Nature 444:429–431 [CrossRef]
    [Google Scholar]
  45. Ritchie D. L., Head M. W., Ironside J. W. 2004; Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl Neurobiol 30:360–368 [CrossRef]
    [Google Scholar]
  46. Saeed S. M., Fine G. 1967; Thioflavin-T for amyloid detection. Am J Clin Pathol 47:588–593
    [Google Scholar]
  47. SCENIHR 2005; The Safety of Human-Derived Products with Regard to Variant Creutzfeldt-Jakob Disease . Edited by the European Commission http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_004.pdf
    [Google Scholar]
  48. Spongiform Encephalopathy Advisory Committee; 2005; Minutes of the open session of the 86th meeting. http://www.seac.gov.uk/minutes/final86.pdf
  49. Surewicz W. K., Jones E. M., Apetri A. C. 2006; The emerging principles of mammalian prion propagation and transmissibility barriers: insight from studies in vitro. Acc Chem Res 39:654–662 [CrossRef]
    [Google Scholar]
  50. UK CJD Surveillance Unit 2006; Creutzfeldt-Jakob disease surveillance in the UK. Fourteenth annual report http://www.cjd.ed.ac.uk/report14.pdf
    [Google Scholar]
  51. Wadsworth J. D., Joiner S., Hill A. F., Campbell T. A., Desbruslais M., Luthert P. J., Collinge J. 2001; Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171–180 [CrossRef]
    [Google Scholar]
  52. Weissmann C., Enari M., Klohn P. C., Rossi D., Flechsig E. 2002; Transmission of prions. Proc Natl Acad Sci U S A 99 (Suppl. 4):16378–16383 [CrossRef]
    [Google Scholar]
  53. Will R. G., Ironside J. W., Zeidler M., Cousens S. N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P. G. 1996; A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921–925 [CrossRef]
    [Google Scholar]
  54. Zobeley E., Flechsig E., Cozzio A., Enari M., Weissmann C. 1999; Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5:240–243
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.82228-0
Loading
/content/journal/jgv/10.1099/vir.0.82228-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error